Navigation Links
Biomarkers allow doctors to match therapy to patient
Date:4/13/2008

SAN DIEGO Genetic variations ensure that no two people are exactly alike, nor are their cancers. Researchers now have the tools and the knowledge to predict how individuals will respond to cancer therapy, enabling more precise and effective treatment. At the 2008 Annual Meeting of the American Association for Cancer Research, April 12 16, researchers present data on new biomarkers that can predict response to well known treatments for breast cancer, pediatric neuroblastoma, and kidney and non-small cell lung cancer.


CD34bright/CD133neg candidate circulating Endothelial Progenitor Cells (ccEPCs) are a potential biomarker during treatment with sunitinib or bevacizumab: Abstract 4956

Researchers have identified two potential biomarkers that could help doctors monitor the effectiveness of treatment with sunitinib or bevacizumab for kidney and non-small cell lung cancer.

Our work provides novel data on a potential biomarker for the monitoring of anti-angiogenic drug activity in cancer patients, as well as identifies a cell type that is a potential target for these agents, said Laura Vroling, M.Sc., a researcher in the Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.

The vascular endothelial growth factor (VEGF) receptor targeted agents bevacizumab and sunitinib have proven effective against several cancers, such as non-small cell lung cancer, colorectal and kidney cancer, but it is unclear which subset of patients will benefit most from these agents, researchers say. Therefore, it is of great importance to identify and validate biomarkers for early response or duration of response, Vroling said.

Vroling and colleagues studied therapy-induced changes in a novel, rare, circulating cell population. They measured these candidate circulating endothelial progenitor cells (ccEPCs) characterized by the markers CD45neg, CD34bright and CD133neg during sunitinib or beva
'/>"/>

Contact: Staci Vernick Goldberg
Staci.goldberg@aacr.org
267-646-0616
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related biology news :

1. Genetic Engineering & Biotechnology News reports on cancer biomarkers
2. A search for biomarkers for early detection of colorectal cancer
3. Colorado Engineering Firms Win NASA Grant to Develop Innovative Insulation for Next Generation Spacecraft - Super-Insulation May Allow Future Energy Efficient Appliances
4. Fine print: New technique allows fast printing of microscopic electronics
5. Rodent fossils allows to determine climate of the Iberian Peninsula 6 million years ago
6. Analysis calls for medical device information to better serve patients and doctors
7. Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling
8. Doctors learn to control their own brains pain responses to better treat patients
9. Patent Issued for e-Smart Technologies, Inc.s First Biometric Match-on-Card Technology
10. Smartcard Finger-Match Add-on for VeriFinger and MegaMatcher is Now Available for the Implementation of Biometric Fingerprint-on-Smartcard Verification Systems
11. Tassie tiger no match for dingo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting its ... and has launched a new marketing campaign to solidify ... (CLO).  The new campaign focuses on First ... and shipments. The first headline in the ... Marken,s priorities with its client,s priorities. Marken recognizes the ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 28, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... present at the upcoming RedChip Global Online CEO Conference ... Gino Pereira , CEO of ... discussing its lead product, the Wocket smart wallet and ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... foot ulcers are a common problem for diabetics and are ... leg amputations in these patients. There is currently no effective ... new research offers hope. French researchers found that diabetic ... prolinespecific molecules found in proteinshowed better wound healing over rats ...
... of the species that inhabit the world,s oceans may remain ... species have been described in the last decade than in ... November 15 in the Cell Press publication Current Biology ... of the worlda massive collaborative undertaking by hundreds of experts ...
... college-age video game enthusiasts teach young surgeons-in-training? ... University of Texas Medical Branch at Galveston (UTMB) ... the superior hand-eye coordination and hand skills gained ... needed to perform today,s most technologically-advanced robotic surgeries. ...
Cached Biology News:Arginine and proline enriched diet may speed wound healing in diabetes 2At least one-third of marine species remain undescribed 2Young gamers offer insight to teaching new physicians robotic surgery 2Young gamers offer insight to teaching new physicians robotic surgery 3
(Date:3/1/2015)... 01, 2015 Market Publishers Ltd ... quality market research promotion on Internet. MarketPublishers.com is ... worked out by DataGroup Booksellers. , Natalie Aster, ... Ltd, commented on the recent partnership agreement as ... in our team of publishers. Since 1974, the ...
(Date:2/27/2015)... A paper published today, " Financing ... in Science Translational Medicine, demonstrates the ... the risk associated with investing in the treatment ... of funding for developing so-called "orphan" drugs. ... between scientists at the National Center for Advancing ...
(Date:2/27/2015)... -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company ... that it will be presenting at CALBIO 2015 at ... at 3pm PST. Patrick Lucy, chief business officer of ... state of the biosimilar industry landscape entitled The ... more information on CALBIO 2015 and The Evolving ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
Breaking Biology Technology:Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5
... AstraZeneca (NYSE:,AZN) today announced that the U.S. Food ... (quetiapine fumarate) Extended-Release,Tablets for the acute treatment of ... and mixed episodes associated with bipolar I,disorder, and ... adjunctive,therapy to lithium or divalproex. SEROQUEL XR is ...
... ENMD ) a clinical-stage pharmaceutical company developing,therapeutics ... today that Thomas H. Bliss, Jr., EntreMed,s Senior ... Company,overview at the 16th Annual BioPartnering Europe Conference, ... United Kingdom. Mr. Bliss, presentation,is scheduled for Monday, ...
... - Ranked Number 7 out of top 20 ... division of Merck KGaA, Darmstadt, Germany, announced,today that it ... employer in the,biotechnology and pharmaceutical industries, ranking number 7 ... "We are honored that the scientific community has ...
Cached Biology Technology:FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9EntreMed to Present at BioPartnering Europe Conference 2EntreMed to Present at BioPartnering Europe Conference 3Merck Serono Named as a Top Employer by Science Magazine 2
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
Mouse polyclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = 25797...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
... The FUNNY SHAKERS are multi-functional mixing devices. ... device is a solid, heavy-duty durable shaker ... both mixing and vortexing in nature. Regulated ... keypad with digital display to control time, ...
Biology Products: